Profiling of desmoid tumors reveals frequent mutations in chromatin-remodeling genes and identifies an Immune-myogenic subtype

Desmoid tumors contain mutations affecting immune response pathways, potentially guiding immunotherapy decisions for patients.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.